FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
HemosIL Factor V Leiden (APC Resistance V)
K Number: K260551
·
Decision Mar 20, 2026
Classifications
1
FEI Numbers
13
Registration Numbers
13
Same Product Code
31
Applicant Total
5
Review Days
30
Basic Information
- Device Name
- HemosIL Factor V Leiden (APC Resistance V)
- K Number
- K260551
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 864.7925
- Medical Specialty
- Hematology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Instrumentation Laboratory (IL) Co.
- Date Received
- February 18, 2026
- Decision Date
- March 20, 2026
- Product Code
- GGW
- Advisory Committee
- Hematology
- Review Advisory Committee
- HE
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| GGW | Test, Time, Partial Thromboplastin | FDA class 2 | Hematology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (GGW), ordered by most recent decision date.
LUPOTEK KCT
FDA 510(k)
FDA Class 2
·Hematology
HEMOCLOT QUANTI- V-L, FACTOR V-L CALIBRATOR, BIOPHEN V-L CAL (UNDILUTED), BIOPHEN ACT. PC-R CONTROL PLASMA AND BIOPHEN
FDA 510(k)
FDA Class 2
·Hematology
CRYOCHECK CLOT APCR
FDA 510(k)
FDA Class 2
·Hematology
PEFAKIT APC-R FACTOR V LEIDEN
FDA 510(k)
FDA Class 2
·Hematology
PHOSPHOLIN ES AND CALCIUM CHLORIDE
FDA 510(k)
FDA Class 2
·Hematology
GRADILEIDEN V TEST
FDA 510(k)
FDA Class 2
·Hematology
Other Clearances by Instrumentation Laboratory (IL) Co.
| K Number | Device Name | ||
|---|---|---|---|
| K253957 | HemosIL Silica Clotting Time | Jan 9, 2026 | Substantially Equivalent |
| K251968 | HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL | Jul 24, 2025 | Substantially Equivalent |
| K243374 | HemosIL CL HIT-IgG(PF4-H) | Jan 28, 2025 | Substantially Equivalent |
| K242127 | ACL TOP Family 50 Series (ACL TOP 750; ACL TOP 750 CTS; ACL TOP 750 LAS; ACL TOP 550 CTS; ACL TOP 350 CTS) | Aug 16, 2024 | Substantially Equivalent |